Pharmacokinetics, Biodistribution, and Stability of Capped Oligodeoxynucleotide Phosphorothioates in Mice
- 1 January 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense Research and Development
- Vol. 3 (3) , 277-284
- https://doi.org/10.1089/ard.1993.3.277
Abstract
Several end-modified oligodeoxynucleotide phosphorothioates (S-oligonucleotides) were studied for their pharmacokinetics, biodistribution, excretion, and metabolic stability in vivo after intravenous administration in mice. The overall tissue distribution and excretion patterns of these S-oligonucleotides were found to be independent of 5′ or 3′ modification studied. However, the 3′ end modification proved to be of considerable importance with respect to metabolic stability of the oligonucleotide. In the case of uncapped and 5′-capped S-oligonucleotide, only 50% of intact oligonucleotide was recovered out of the total bioavailable concentration in liver and kidney. In contrast, in the case of 3′-capped oligonucleotides almost all bioavailable concentrations of 3′-capped oligonucleotide was found to be intact in kidney and liver at 24 hr after administration. These results demonstrate that superior pharmaceutical potential can be created by 3′-end modification of oligonucleotide phosphorothioates.Keywords
This publication has 21 references indexed in Scilit:
- Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.Proceedings of the National Academy of Sciences, 1992
- GEM* 91—An Antisense Oligonucleotide Phosphorothioate as a Therapeutic Agent for AIDSAntisense Research and Development, 1992
- Oligodeoxynucleotides as Antisense Inhibitors of Gene ExpressionProgress in Nucleic Acid Research and Molecular Biology, 1992
- Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.Proceedings of the National Academy of Sciences, 1991
- Substrate Specificity and Kinetics of Degradation of Antisense Oligonucleotides by a 3′ Exonuclease in PlasmaAntisense Research and Development, 1991
- Effects of phosphorothioate capping on antivense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infectionNucleic Acids Research, 1991
- Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.Proceedings of the National Academy of Sciences, 1989
- Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1988
- Oligodeoxynucleoside methylphosphonates: synthesis and enzymic degradationTetrahedron Letters, 1987
- Nucleoside h-phosphonates: Valuable intermediates in the synthesis of deoxyoligonucleotidesTetrahedron Letters, 1986